Company Filing History:
Years Active: 1983
Title: Massimo Brunetti: Innovator in Organ Transplant Technology
Introduction
Massimo Brunetti is a notable inventor based in Birsfelden, Switzerland. He has made significant contributions to the field of organ transplantation, particularly through his innovative patent that addresses the preparation of new organ transplants. His work aims to provide effective replacements for organs or parts of organs that have undergone pathological changes or are functionally impaired.
Latest Patents
Brunetti holds a patent for a "Process for the preparation of new organ transplants." This patent outlines a method for creating prostheses from organs taken from fish, birds, or higher mammals. The process involves crosslinking amino groups and alcoholic hydroxyl groups of the peptide chains in the intercellular matrix using di-, tri-, or poly-carboxylic acids. Following this, the crosslinked product is treated with a dialdehyde to bind unreacted amino groups or to remove potential antigens through hydrolysis with enzymes such as ficin, papain, or proteases. The resulting prostheses exhibit chemical stability and biophysical properties similar to natural materials, minimizing the risk of rejection reactions.
Career Highlights
Massimo Brunetti is associated with Solco Basel AG, where he continues to advance his research and development in organ transplant technology. His innovative approach has the potential to revolutionize the field and improve the quality of life for patients requiring organ replacements.
Collaborations
Brunetti has collaborated with notable colleagues, including Wolfgang Fraefel and Heinz F Lichti, who have contributed to his research endeavors. Their combined expertise enhances the development of effective solutions in organ transplantation.
Conclusion
Massimo Brunetti's work in the preparation of new organ transplants represents a significant advancement in medical technology. His innovative methods and collaborations are paving the way for improved organ replacement solutions, ultimately benefiting patients in need.